- Home
- DAWN vs CNEY Comparison
DAWN vs CNEY Comparison
Compare DAWN & CNEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAWN | CNEY |
|---|---|---|
| Founded | 2018 | 2018 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 624.8M | 11.3M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DAWN | CNEY |
|---|---|---|
| Price | $9.45 | $0.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $26.56 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 1.9M |
| Earning Date | 11-04-2025 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $133,672,000.00 | $36,049,275.00 |
| Revenue This Year | $15.51 | N/A |
| Revenue Next Year | $49.99 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 31.11 | N/A |
| 52 Week Low | $5.64 | $0.53 |
| 52 Week High | $13.53 | $12.23 |
Technical Indicators
Market Signals| Indicator | DAWN | CNEY |
|---|---|---|
| Relative Strength Index (RSI) | 58.46 | 18.67 |
| Support Level | $8.13 | $0.57 |
| Resistance Level | $9.82 | $0.64 |
| Average True Range (ATR) | 0.59 | 0.07 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 64.40 | 0.00 |
Price Performance
Historical ComparisonAbout DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About CNEY CN Energy Group Inc.
CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.